Europe Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

October 2022 | 121 pages | ID: E7591E1FF277EN
GMD Research

Abstracts

Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.

Highlighted with 42 tables and 37 figures, this 121-page report “Europe Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.

Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Software
• Services

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

10x Genomics

Agilent Technologies, Inc.

ANGLE plc

Becton, Dickinson and Company (BD)

Bio-Rad Laboratories, Inc.

BioSypder, Inc.

Bio-Techne

Cytiva

F. Hoffmann-La Roche Ltd.

Fluidigm Corporation

GE Healthcare

Illumina, Inc.

Menarini Silicon Biosystems

Merck & Co., Inc.

NanoString

Pacific Biosciences of California, Inc.

PerkinElmer Inc.

Promega Corporation

Qiagen N. V.

Takara Bio Inc.

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY COMPONENT

3.1 Market Overview by Component
3.2 Instruments
3.3 Consumables
3.4 Software
3.5 Services

4 SEGMENTATION OF EUROPE MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.3 Next-Generation Sequencing
4.4 Microarray
4.5 In-Situ Hybridization (ISH)
4.6 Gene Regulation Technologies
4.7 Other Technologies

5 SEGMENTATION OF EUROPE MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Drug Discovery and Development
5.3 Diagnostics
5.4 Single Cell Analysis
5.5 Gene Expression
5.6 Cell Biology
5.7 Other Applications

6 SEGMENTATION OF EUROPE MARKET BY END USER

6.1 Market Overview by End User
6.2 Academic and Research Institutions
6.3 Biotechnology and Biopharmaceutical Companies
6.4 Contract Research Organizations (CROs)
6.5 Other End Users

7 EUROPEAN MARKET 2021-2031 BY COUNTRY

7.1 Overview of European Market
7.2 Germany
7.3 U.K.
7.4 France
7.5 Spain
7.6 Italy
7.7 Netherlands
7.8 Rest of European Market

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles

10X GENOMICS

Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Europe Transcriptomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Transcriptome Databases
Table 4. World Personalized Medicine Market, 2021-2031, $ bn
Table 5. Main Product Trends and Market Opportunities in Europe Transcriptomics Market
Table 6. Europe Transcriptomics Market by Component, 2021-2031, $ mn
Table 7. Main Instrument Products from Key Vendors
Table 8. Main Consumable Products from Key Vendors
Table 9. Main Software Products from Key Vendors
Table 10. Europe Transcriptomics Market by Technology, 2021-2031, $ mn
Table 11. Main PCR-based Transcriptomics and Key Vendors
Table 12. Main NGS-based Transcriptomics and Key Vendors
Table 13. Main Microarray-based Transcriptomics and Key Vendors
Table 14. Main ISH-based Transcriptomics and Key Vendors
Table 15. Europe Transcriptomics Market by Application, 2021-2031, $ mn
Table 16. Europe Transcriptomics Market by End User, 2021-2031, $ mn
Table 17. Europe Transcriptomics Market by Country, 2021-2031, $ mn
Table 18. Germany Transcriptomics Market by Component, 2021-2031, $ mn
Table 19. Germany Transcriptomics Market by Technology, 2021-2031, $ mn
Table 20. Germany Transcriptomics Market by Application, 2021-2031, $ mn
Table 21. U.K. Transcriptomics Market by Component, 2021-2031, $ mn
Table 22. U.K. Transcriptomics Market by Technology, 2021-2031, $ mn
Table 23. U.K. Transcriptomics Market by Application, 2021-2031, $ mn
Table 24. France Transcriptomics Market by Component, 2021-2031, $ mn
Table 25. France Transcriptomics Market by Technology, 2021-2031, $ mn
Table 26. France Transcriptomics Market by Application, 2021-2031, $ mn
Table 27. Spain Transcriptomics Market by Component, 2021-2031, $ mn
Table 28. Spain Transcriptomics Market by Technology, 2021-2031, $ mn
Table 29. Spain Transcriptomics Market by Application, 2021-2031, $ mn
Table 30. Italy Transcriptomics Market by Component, 2021-2031, $ mn
Table 31. Italy Transcriptomics Market by Technology, 2021-2031, $ mn
Table 32. Italy Transcriptomics Market by Application, 2021-2031, $ mn
Table 33. Netherlands Transcriptomics Market by Component, 2021-2031, $ mn
Table 34. Netherlands Transcriptomics Market by Technology, 2021-2031, $ mn
Table 35. Netherlands Transcriptomics Market by Application, 2021-2031, $ mn
Table 36. Transcriptomics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 37. Transcriptomic Products Approved by FDA
Table 38. Sequencing Technology Platforms for RNA-Sequencing
Table 39. RNA-Sequencing De Novo Assembly Software
Table 40. 10x Genomics: Company Snapshot
Table 41. 10x Genomics: Business Segmentation
Table 42. 10x Genomics: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Europe Transcriptomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Transcriptomics Market
Figure 7. Primary Restraints and Impact Factors of Europe Transcriptomics Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Europe Transcriptomics Market
Figure 10. Breakdown of Europe Transcriptomics Market by Component, 2021-2031, % of Revenue
Figure 11. Europe Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)
Figure 12. Europe Transcriptomics Market by Component: Instruments, 2021-2031, $ mn
Figure 13. Europe Transcriptomics Market by Component: Consumables, 2021-2031, $ mn
Figure 14. Europe Transcriptomics Market by Component: Software, 2021-2031, $ mn
Figure 15. Europe Transcriptomics Market by Component: Services, 2021-2031, $ mn
Figure 16. Breakdown of Europe Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue
Figure 17. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 18. Europe Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 19. Europe Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn
Figure 20. Europe Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn
Figure 21. Europe Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn
Figure 22. Europe Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn
Figure 23. Europe Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 24. Breakdown of Europe Transcriptomics Market by Application, 2021-2031, % of Sales Revenue
Figure 25. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 26. Europe Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn
Figure 27. Europe Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn
Figure 28. Europe Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn
Figure 29. Europe Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn
Figure 30. Europe Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn
Figure 31. Europe Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn
Figure 32. Breakdown of Europe Transcriptomics Market by End User, 2021-2031, % of Revenue
Figure 33. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 34. Europe Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn
Figure 35. Europe Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn
Figure 36. Europe Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 37. Europe Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 38. Breakdown of European Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 39. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 40. Transcriptomics Market in Germany, 2021-2031, $ mn
Figure 41. Transcriptomics Market in U.K., 2021-2031, $ mn
Figure 42. Transcriptomics Market in France, 2021-2031, $ mn
Figure 43. Transcriptomics Market in Spain, 2021-2031, $ mn
Figure 44. Transcriptomics Market in Italy, 2021-2031, $ mn
Figure 45. Transcriptomics Market in Netherlands, 2021-2031, $ mn
Figure 46. Transcriptomics Market in Rest of Europe, 2021-2031, $ mn
Figure 47. Growth Stage of Europe Transcriptomics Industry over the Forecast Period